Insulet Corporation (PODD) Key Metrics
PODD valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $9.79B
- Enterprise value
- $9.88B
- P/E (TTM)
- 26.4 10-yr median 80.1
- Forward P/E
- 54.9
- PEG ratio
- 3.31
- Price / sales
- 3.2 10-yr median 9.4
- Price / book
- 15.0 10-yr median 26.6
- EV / EBITDA
- 54.6 10-yr median 134.2
- Dividend yield
- —
- Beta
- 1.10
PODD key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsPODD valuation Price multiples at each fiscal year-end price.
PODD returns How much profit the business earns on the capital it uses.
PODD per-share figures Results divided by the shares outstanding at year-end.
PODD financial health Debt, liquidity and how easily interest is covered.
PODD efficiency & capital use Working capital cycle and where the cash goes.
PODD valuation history
PODD returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
PODD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
PODD cash returned to shareholders
PODD price vs earnings per share
PODD key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $20.43B | $19.29B | $15.98B | $20.58B | $18.25B | $16.86B | $10.67B | $4.84B | $4.00B | $2.16B |
| Enterprise value | $20.77B | $19.76B | $16.72B | $21.34B | $18.73B | $16.97B | $11.18B | $5.14B | $4.13B | $2.19B |
| P/E ratio | 82.7 | 46.1 | 77.4 | — | — | — | 919.5 | — | — | — |
| Price / sales | 7.5 | 9.3 | 9.4 | 15.8 | 16.6 | 18.6 | 14.4 | 8.6 | 8.6 | 5.9 |
| Price / book | 13.5 | 15.9 | 21.8 | 43.2 | 32.8 | 27.9 | 140.5 | 22.8 | 25.2 | 34.2 |
| Price / free cash flow | 54.1 | 63.2 | 227.9 | — | — | — | — | — | — | — |
| Price / operating cash flow | 35.9 | 44.8 | 109.7 | 172.9 | — | 200.7 | 108.4 | 134.8 | 96.9 | 135.6 |
| EV / sales | 7.7 | 9.5 | 9.9 | 16.3 | 17.0 | 18.8 | 15.1 | 9.1 | 8.9 | 6.0 |
| EV / EBITDA | 40.8 | 46.6 | 51.7 | 195.8 | 134.2 | 153.8 | 150.7 | 119.4 | 638.4 | — |
| EV / free cash flow | 55.0 | 64.7 | 238.5 | — | — | — | — | — | — | — |
| Earnings yield | 1.2% | 2.2% | 1.3% | 0.0% | 0.1% | 0.0% | 0.1% | 0.1% | −0.7% | −1.3% |
| Free cash flow yield | 1.8% | 1.6% | 0.4% | −0.2% | −1.0% | −0.5% | −0.7% | −2.6% | −0.9% | −0.3% |
| Dividend yield | — | — | 0.1% | — | 0.1% | 0.6% | 0.1% | — | 0.0% | 0.0% |
| Shareholder yield (dividends + buybacks) | 0.3% | 0.0% | 0.1% | 0.1% | 0.3% | 0.8% | 0.2% | 0.4% | 0.1% | 0.1% |
| Share price at fiscal year-end | $284.24 | $261.07 | $216.98 | $294.39 | $266.07 | $255.63 | $171.20 | $79.32 | $69.00 | $37.68 |
| Per share | ||||||||||
| Revenue per share | $37.67 | $28.04 | $23.05 | $18.67 | $16.02 | $13.71 | $11.85 | $9.24 | $8.00 | $6.41 |
| Earnings per share | $3.44 | $5.66 | $2.80 | $0.07 | $0.24 | $0.10 | $0.19 | $0.05 | −$0.46 | −$0.50 |
| Operating cash flow per share | $7.92 | $5.82 | $1.98 | $1.70 | −$0.99 | $1.27 | $1.58 | $0.59 | $0.71 | $0.28 |
| Free cash flow per share | $5.25 | $4.13 | $0.95 | −$0.55 | −$2.78 | −$1.25 | −$1.16 | −$2.07 | −$0.62 | −$0.11 |
| Cash per share | $9.96 | $12.90 | $9.56 | $9.65 | $11.54 | $14.37 | $6.04 | $4.74 | $7.59 | $5.22 |
| Book value per share | $21.08 | $16.40 | $9.95 | $6.81 | $8.11 | $9.15 | $1.22 | $3.48 | $2.73 | $1.10 |
| Tangible book value per share | $18.73 | $14.37 | $7.91 | $4.99 | $7.00 | $8.11 | $0.37 | $2.66 | $1.97 | $0.40 |
| Dividends per share | — | — | $0.14 | — | $0.34 | $1.49 | $0.14 | — | $0.00 | $0.00 |
| Capex per share | $2.67 | $1.69 | $1.03 | $2.25 | $1.79 | $2.52 | $2.74 | $2.66 | $1.33 | $0.39 |
| Debt per share | $14.62 | $19.24 | $19.68 | $20.49 | $18.58 | $16.06 | $14.31 | $9.70 | $9.76 | $5.82 |
| Shares outstanding | 71.9M | 73.9M | 73.6M | 69.9M | 68.6M | 65.9M | 62.3M | 61.0M | 58.0M | 57.3M |
| Change in shares outstanding | −2.7% | +0.3% | +5.3% | +1.9% | +4.0% | +5.8% | +2.1% | +5.2% | +1.3% | +0.8% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 18.1% | 43.0% | 34.1% | 0.9% | 2.9% | 2.0% | 8.1% | 1.8% | −24.2% | −59.4% |
| Return on invested capital (ROIC) | 19.5% | 19.6% | 15.6% | 1.7% | 11.8% | 5.5% | 7.2% | 4.3% | −3.1% | −9.1% |
| Return on assets (ROA) | 7.9% | 14.7% | 8.5% | 0.2% | 0.9% | 0.5% | 1.1% | 0.4% | −4.2% | −7.9% |
| Return on tangible assets | 8.2% | 14.2% | 8.5% | 0.2% | 0.9% | 0.4% | 1.1% | 0.4% | −3.5% | −6.9% |
| Free cash flow margin | 13.9% | 14.7% | 4.1% | −2.9% | −17.4% | −9.1% | −9.8% | −22.4% | −7.8% | −1.7% |
| Income quality (OCF / net income) | 2.30 | 1.03 | 0.71 | 25.87 | −4.05 | 12.35 | 8.48 | 10.91 | — | — |
| Financial health | ||||||||||
| Total debt | $1.05B | $1.42B | $1.45B | $1.43B | $1.27B | $1.06B | $891.5M | $592.0M | $566.2M | $333.0M |
| Cash & short-term investments | $716.1M | $953.4M | $704.2M | $674.7M | $791.6M | $947.6M | $376.1M | $288.9M | $440.1M | $298.6M |
| Net debt | $334.7M | $468.6M | $744.6M | $758.1M | $482.3M | $111.7M | $515.4M | $303.0M | $126.1M | $34.5M |
| Debt / equity | 0.69 | 1.17 | 1.98 | 3.01 | 2.29 | 1.75 | 11.75 | 2.79 | 3.57 | 5.27 |
| Debt / assets | 0.33 | 0.46 | 0.56 | 0.64 | 0.62 | 0.57 | 0.78 | 0.64 | 0.69 | 0.73 |
| Net debt / EBITDA | 0.66 | 1.11 | 2.30 | 6.96 | 3.45 | 1.01 | 6.95 | 7.04 | 19.50 | 24.57 |
| Current ratio | 2.78 | 3.54 | 3.47 | 3.56 | 5.81 | 6.01 | 3.75 | 3.93 | 6.24 | 6.64 |
| Quick ratio | 2.11 | 2.73 | 2.58 | 2.61 | 4.49 | 5.27 | 3.11 | 3.31 | 5.85 | 6.00 |
| Interest coverage | 5.9 | 7.2 | 6.1 | 1.0 | 2.0 | 1.1 | 1.4 | 1.2 | -0.4 | -0.7 |
| Working capital | $1.21B | $1.34B | $1.12B | $934.1M | $1.10B | $1.04B | $433.3M | $338.4M | $451.1M | $314.3M |
| Invested capital | $1.85B | $1.68B | $1.48B | $1.23B | $1.04B | $715.3M | $591.3M | $515.1M | $284.6M | $97.6M |
| Tangible asset value | $1.35B | $1.06B | $582.3M | $349.2M | $479.9M | $535.1M | $22.9M | $162.1M | $114.3M | $22.9M |
| Net current asset value | $213.5M | −$4.9M | −$289.2M | −$475.9M | −$162.7M | −$20.6M | −$476.0M | −$262.6M | −$121.1M | −$23.5M |
| Graham number | $40.38 | $45.70 | $25.05 | $3.18 | $6.69 | $4.61 | $2.26 | $2.05 | — | — |
| Graham net-net per share | −$4.80 | −$5.87 | −$9.24 | −$11.05 | −$6.25 | −$2.76 | −$9.28 | −$5.48 | −$2.78 | −$0.97 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | $10.6M | — | $23.5M | $98.5M | $8.6M | — | $0 | $0 |
| Share buybacks (net) | $59.6M | $0 | $0 | $16.8M | $28.2M | $29.8M | $8.6M | $17.8M | $4.1M | $2.9M |
| Dividend payout ratio | — | — | 5.1% | — | 139.9% | — | 74.1% | — | — | — |
| Dividends + buybacks / free cash flow | 15.8% | 0.0% | 15.1% | — | — | — | — | — | — | — |
| Capex / revenue | 7.1% | 6.0% | 4.5% | 12.1% | 11.2% | 18.4% | 23.2% | 28.8% | 16.7% | 6.0% |
| Capex / operating cash flow | 33.7% | 29.0% | 51.9% | 132.2% | — | 198.2% | 173.7% | 452.2% | 187.0% | 139.0% |
| Capex / depreciation | 2.12 | 1.55 | 1.04 | 2.49 | 2.14 | 3.01 | 6.13 | 10.41 | 5.56 | 1.60 |
| Stock-based compensation / revenue | 2.3% | 3.3% | 2.8% | 3.1% | 3.1% | 4.0% | 3.9% | 6.7% | 6.9% | 6.4% |
| R&D / revenue | 11.1% | 10.6% | 12.1% | 13.8% | 14.6% | 16.2% | 17.9% | 15.7% | 16.1% | 15.2% |
| SG&A / revenue | 43.0% | 44.3% | 43.3% | 43.5% | 42.4% | 42.5% | 40.7% | 45.1% | 45.3% | 45.3% |
| Efficiency | ||||||||||
| Days sales outstanding | 59.5 | 63.9 | 60.8 | 51.3 | 40.7 | 33.6 | 39.4 | 42.1 | 32.3 | 35.5 |
| Days of inventory on hand | 209.8 | 242.9 | 254.6 | 237.4 | 240.8 | 144.7 | 122.0 | 99.1 | 67.8 | 55.6 |
| Days payables outstanding | 22.5 | 11.4 | 17.0 | 25.0 | 48.3 | 61.5 | 56.6 | 47.0 | 36.7 | 33.2 |
| Cash conversion cycle (days) | 246.7 | 295.4 | 298.4 | 263.6 | 233.2 | 116.7 | 104.8 | 94.2 | 63.4 | 57.9 |
| Receivables turnover | 6.14 | 5.71 | 6.00 | 7.12 | 8.98 | 10.86 | 9.26 | 8.67 | 11.29 | 10.29 |
| Payables turnover | 16.21 | 32.10 | 21.49 | 14.59 | 7.55 | 5.93 | 6.45 | 7.76 | 9.93 | 10.99 |
| Inventory turnover | 1.74 | 1.50 | 1.43 | 1.54 | 1.52 | 2.52 | 2.99 | 3.68 | 5.38 | 6.56 |
| Asset turnover | 0.86 | 0.73 | 0.70 | 0.61 | 0.56 | 0.60 | 0.71 | 0.65 | 0.73 | 1.00 |
| Average receivables | $441.2M | $362.6M | $282.6M | $183.3M | $122.4M | $83.3M | $79.7M | $65.0M | $41.1M | $35.7M |
| Average payables | $47.4M | $19.5M | $25.0M | $34.2M | $45.9M | $54.3M | $40.0M | $25.0M | $18.8M | $14.2M |
| Average inventory | $441.5M | $416.5M | $374.7M | $325.0M | $228.8M | $127.7M | $86.2M | $52.6M | $34.7M | $23.8M |
| Intangibles / total assets | 5.3% | 4.9% | 5.8% | 5.7% | 3.7% | 3.7% | 4.6% | 5.4% | 5.4% | 8.8% |
Computed from PODD's annual financial statements (latest annual report filed February 18, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
PODD valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Insulet traded at 82.7 times earnings, against a 10-year median of 80.1. Based on the latest twelve months, the trailing P/E is 26.4 and the forward P/E is 54.9. Insulet earned a return on equity of 18.1% and a return on invested capital of 19.5% in fiscal 2025. It ended the year with $1.1 billion of debt and $716.1 million in cash and short-term investments, net debt of $334.7 million. It returned $59.6 million to shareholders: $0 in dividends and $59.6 million in share buybacks, 16% of free cash flow. The share count rose 25.6% from 57.3M to 71.9M over 9 years.
See the PODD income statement, the PODD chart for price history, or the PODD stock overview for the latest quote and news.
PODD key metrics FAQ
What is Insulet's P/E ratio?
Insulet's trailing P/E ratio is 26.4 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 54.9. At the end of fiscal 2025 it was 82.7, compared with a 10-year median of 80.1.
What is Insulet's EV/EBITDA?
Insulet's enterprise value was 40.8 times EBITDA at the end of fiscal 2025 (enterprise value $20.8 billion, EBITDA $509.6 million); the current EV/EBITDA is 54.6.
What is Insulet's return on equity?
Insulet's return on equity (ROE) was 18.1% in fiscal 2025: net income of $247.1 million on average shareholders' equity of $1.4 billion.
What is Insulet's ROIC?
Insulet's return on invested capital was 19.5% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Insulet have?
Insulet had total debt of $1.1 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.69 and $334.7 million of net debt (0.66 times EBITDA).
Does Insulet buy back its shares?
Yes. Insulet spent $59.6 million on net share repurchases in fiscal 2025 Shares outstanding changed −2.7% over the year, to 71.9M..
What is Insulet's free cash flow yield?
Insulet generated $377.7 million of free cash flow in fiscal 2025, a free cash flow yield of 1.8% on its market value at year-end ($20.4 billion).
What is Insulet's current ratio?
Insulet's current ratio was 2.78 at the end of fiscal 2025: current assets were 2.78 times current liabilities.